Apc mutation enhances pyMT-induced mammary tumorigenesis

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Prosperi, Jenifer R ^a   Khramtsov, Andrey I ^a   Khramtsova, Galina F ^a   Goss, Kathleen H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; VIRUS MIDDLE T ANTIGEN; BETA CATENIN; VIRUS T ANTIGEN; WNT PROTEIN;

ADENOMATOUS POLYPOSIS COLI GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APC GENE; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; BREAST SQUAMOUS ADENOCARCINOMA; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE LOSS; GENETIC CROSS; HETEROZYGOSITY; MALE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; POLYOMA VIRUS; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR CELL; TUMOR CELL LINE; TUMOR MODEL; TUMOR SUPPRESSOR GENE; ANIMAL; APOPTOSIS; C57BL MOUSE; EXPERIMENTAL NEOPLASM; GENETICS; IMMUNOLOGY; METABOLISM; MUTATION; PATHOLOGY; VIROLOGY; WESTERN BLOTTING;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; BETA CATENIN; BLOTTING, WESTERN; CELL PROLIFERATION; GENES, APC; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; WNT PROTEINS;

EID: 84055207526     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029339     Document Type: Article

References (65)

1. Prosperi JR, Goss KH, (2010) A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer. Curr Drug Targets 11: 1074-1088.
2. Van der Auwera I, Van Laere SJ, Van den Bosch SM, Van den Eynden GG, Trinh BX, et al. (2008) Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. Br J Cancer 99: 1735-1742.
3. Hayes MJ, Thomas D, Emmons A, Giordano TJ, Kleer CG, (2008) Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast. Clin Cancer Res 14: 4038-4044.
4. Prasad CP, Mirza S, Sharma G, Prashad R, DattaGupta S, et al. (2008) Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. Life Sci 83: 318-325.
5. Moser AR, Pitot HC, Dove WF, (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324.
6. Nakayama T, Yamazumi K, Uemura T, Yoshizaki A, Yakata Y, et al. (2007) X radiation up-regulates the occurrence and the multiplicity of invasive carcinomas in the intestinal tract of Apc(min/+) mice. Radiat Res 168: 433-439.
7. Imaoka T, Okamoto M, Nishimura M, Nishimura Y, Ootawara M, et al. (2006) Mammary tumorigenesis in ApcMin/+ mice is enhanced by X irradiation with a characteristic age dependence. Radiat Res 165: 165-173.
8. Prosperi JR, Becher KR, Willson TA, Collins MH, Witte DP, et al. (2009) The APC tumor suppressor is required for epithelial integrity in the mouse mammary gland. J Cell Physiol 220: 319-331.
9. van der Houven van Oordt CW, Smits R, Schouten TG, Houwing-Duistermaat JJ, Williamson SL, et al. (1999) The genetic background modifies the spontaneous and X-ray-induced tumor spectrum in the Apc1638N mouse model. Genes Chromosomes Cancer 24: 191-198.
10. van der Houven van Oordt CW, Smits R, Williamson SL, Luz A, Khan PM, et al. (1997) Intestinal and extra-intestinal tumor multiplicities in the Apc1638N mouse model after exposure to X-rays. Carcinogenesis 18: 2197-2203.
11. Sasai H, Masaki M, Wakitani K, (2000) Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522. Carcinogenesis 21: 953-958.
12. Brennan KR, Brown AM, (2004) Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia 9: 119-131.
13. Gallagher RC, Hay T, Meniel V, Naughton C, Anderson TJ, et al. (2002) Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency. Oncogene 21: 6446-6457.
14. Kuraguchi M, Ohene-Baah NY, Sonkin D, Bronson RT, Kucherlapati R, (2009) Genetic mechanisms in Apc-mediated mammary tumorigenesis. PLoS Genet 5: e1000367.
15. Gaspar C, Franken P, Molenaar L, Breukel C, van der Valk M, et al. (2009) A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis. PLoS Genet 5: e1000547.
16. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113.
17. Guy CT, Cardiff RD, Muller WJ, (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12: 954-961.
18. Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, et al. (2007) N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Res 67: 3106-3116.
19. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, et al. (2004) Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 279: 51630-51646.
20. Maroulakou IG, Oemler W, Naber SP, Tsichlis PN, (2007) Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res 67: 167-177.
21. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, et al. (2003) Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 163: 2113-2126.
22. Fluck MM, Schaffhausen BS, (2009) Lessons in signaling and tumorigenesis from polyomavirus middle T antigen. Microbiol Mol Biol Rev 73: 542-563.
23. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, et al. (1992) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A 89: 10578-10582.
24. Sarkar FH, Li YW, Crissman JD, (1993) A method for PCR sequencing of the p53 gene from a single 10-microns frozen or paraffin-embedded tissue section. Biotechniques 15: 36-38.
25. Luongo C, Moser AR, Gledhill S, Dove WF, (1994) Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 54: 5947-5952.
26. D'Abaco GM, Whitehead RH, Burgess AW, (1996) Synergy between Apc min and an activated ras mutation is sufficient to induce colon carcinomas. Mol Cell Biol 16: 884-891.
27. Khramtsov AI, Khramtsova GF, Tretiakova M, Huo D, Olopade OI, et al. (2010) Wnt/{beta}-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome. Am J Pathol.
28. Heinen CD, Goss KH, Cornelius JR, Babcock GF, Knudsen ES, et al. (2002) The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway. Gastroenterology 123: 751-763.
29. Prosperi JR, Goss KH, (2011) Wnt Pathway-Independent Activities of the APC Tumor Suppressor Tumor Suppressors (Ed Susan D Nguyen).
30. Playford MP, Schaller MD, (2004) The interplay between Src and integrins in normal and tumor biology. Oncogene 23: 7928-7946.
31. Oktay M, Wary KK, Dans M, Birge RB, Giancotti FG, (1999) Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle. J Cell Biol 145: 1461-1469.
32. Schlaepfer DD, Mitra SK, Ilic D, (2004) Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 1692: 77-102.
33. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ, (1994) Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 8: 23-32.
34. Spicer AP, Rowse GJ, Lidner TK, Gendler SJ, (1995) Delayed mammary tumor progression in Muc-1 null mice. J Biol Chem 270: 30093-30101.
35. Adriance MC, Gendler SJ, (2004) Downregulation of Muc1 in MMTV-c-Neu tumors. Oncogene 23: 697-705.
36. Andrechek ER, Muller WJ, (2000) Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer. Breast Cancer Res 2: 211-216.
37. Amundadottir LT, Leder P, (1998) Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene 16: 737-746.
38. Troyer KL, Lee DC, (2001) Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network. J Mammary Gland Biol Neoplasia 6: 7-21.
39. Zhou BP, Hung MC, (2003) Dysregulation of cellular signaling by HER2/neu in breast cancer. Semin Oncol 30: 38-48.
40. Wang H, Teske D, Tess A, Kohlhepp R, Choi Y, et al. (2007) Identification of novel modifier loci of Apc Min affecting mammary tumor development. Cancer Res 67: 11226-11233.
41. Pecina-Slaus N, Nikuseva Martic T, Zeljko M, Bulat S, (2011) Brain metastases exhibit gross deletions of the APC gene. Brain Tumor Pathol 28: 223-8.
42. DiMeo TA, Anderson K, Phadke P, Fan C, Perou CM, et al. (2009) A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res 69: 5364-5373.
43. Klemm F, Bleckmann A, Siam L, Chuang HN, Rietkotter E, et al. (2010) beta-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis 32: 434-442.
44. Previdi S, Maroni P, Matteucci E, Broggini M, Bendinelli P, et al. (2010) Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and beta-catenin/Wnt pathways. Eur J Cancer 46: 1679-1691.
45. Miyoshi K, Rosner A, Nozawa M, Byrd C, Morgan F, et al. (2002) Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene 21: 5548-5556.
46. Miyoshi K, Shillingford JM, Le Provost F, Gounari F, Bronson R, et al. (2002) Activation of beta-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc Natl Acad Sci U S A 99: 219-224.
47. Renou JP, Bierie B, Miyoshi K, Cui Y, Djiane J, et al. (2003) Identification of genes differentially expressed in mouse mammary epithelium transformed by an activated beta-catenin. Oncogene 22: 4594-4610.
48. Meniel V, Hay T, Douglas-Jones A, Sansom OJ, Clarke AR, (2005) Mutations in Apc and p53 synergize to promote mammary neoplasia. Cancer Res 65: 410-416.
49. Li W, Qiao W, Chen L, Xu X, Yang X, et al. (2003) Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice. Development 130: 6143-6153.
50. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, et al. (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669-671.
51. Pirkmaier A, Dow R, Ganiatsas S, Waring P, Warren K, et al. (2003) Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma. Oncogene 22: 4425-4433.
52. Liu B, Yu HM, Huang J, Hsu W, (2008) Co-opted JNK/SAPK signaling in Wnt/beta-catenin-induced tumorigenesis. Neoplasia 10: 1004-1013.
53. Zhang Y, Neo SY, Wang X, Han J, Lin SC, (1999) Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling. J Biol Chem 274: 35247-35254.
54. Wang J, Kuiatse I, Lee AV, Pan J, Giuliano A, et al. (2010) Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation. Mol Cancer Res 8: 266-277.
55. Sieg DJ, Hauck CR, Schlaepfer DD, (1999) Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci 112 (Pt 16): 2677-2691.
56. Ashton GH, Morton JP, Myant K, Phesse TJ, Ridgway RA, et al. (2010) Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling. Dev Cell 19: 259-269.
57. Etienne-Manneville S, Manneville JB, Nicholls S, Ferenczi MA, Hall A, (2005) Cdc42 and Par6-PKCzeta regulate the spatially localized association of Dlg1 and APC to control cell polarization. J Cell Biol 170: 895-901.
58. Etienne-Manneville S, Hall A, (2003) Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 421: 753-756.
59. Nathke IS, Adams CL, Polakis P, Sellin JH, Nelson WJ, (1996) The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. Journal of Cell Biology 134: 165-179.
60. Guo W, Giancotti FG, (2004) Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5: 816-826.
61. Schmitz KJ, Grabellus F, Callies R, Otterbach F, Wohlschlaeger J, et al. (2005) High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome. Breast Cancer Res 7: R194-203.
62. Lark AL, Livasy CA, Dressler L, Moore DT, Millikan RC, et al. (2005) High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype. Mod Pathol 18: 1289-1294.
63. Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF, et al. (2009) Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 119: 252-266.
64. Marcotte R, Smith HW, Sanguin-Gendreau V, McDonough RV, Muller WJ, (2011) Breast Cancer Special Feature: Mammary epithelial-specific disruption of c-Src impairs cell cycle progression and tumorigenesis. Proc Natl Acad Sci U S A.
65. Lahlou H, Sanguin-Gendreau V, Zuo D, Cardiff RD, McLean GW, et al. (2007) Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci U S A 104: 20302-20307.